Funding available for innovative computational genomics research with broad applications in human health, focusing on developing analytical methods, tools, and software.
Funder: National Institutes of Health
Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | February 16, 2027 (New) | March 16, 2027 (Renewal/Resubmission/Revision) | June 16, 2027 (New) | July 16, 2027 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.
Summary: Supports innovative, broadly applicable computational genomics and data science research, including new analytical methods, tools, and software relevant to human health.
Key Information: Clinical trials are not allowed; foreign organizations are eligible; applications must focus on innovation, not incremental improvements.
This opportunity supports investigator-initiated research projects that advance innovation in computational genomics, data science, statistics, and bioinformatics. The focus is on developing new analytical methodologies, early-stage tools and software, and refining or hardening software of high value to the biomedical genomics community. Projects must be broadly enabling for genomics, generalizable across diseases and biological systems, and scalable to large datasets. The program is designed to catalyze advances that are widely applicable to human health and disease, rather than incremental improvements or disease-specific solutions.
Research topics of interest include, but are not limited to:
Applicants are encouraged to propose creative, forward-thinking research beyond these examples.
Note: Projects focused on microbial genomics, maintenance/extension of existing resources, non-generalizable methods, ontology/curation, or basic data science not developed for genomics are not responsive and will not be reviewed.